Company · Ownership research

Allogene Therapeutics, Inc. ALLO

CIK 0001737287

Form 4 transactions dated Nov 1, 2023 to Nov 9, 2026, as reported to the SEC.

Insider trading Initial holdings Institutional holders

Insider filings on file run through Oct 23, 2026.

Insider purchases & sales

Purchased: $5.00M
Sold: $1.28M

Nov 1, 2023 – Oct 23, 2026
Available records · partial months are marked ·

20246 of 6 preview events

Date	Insider	Activity	Trade value (USD)	% of prior holding
Dec 9, 2024	MESSEMER DEBORAH M. Director	Sale	$19.92K 9,136 shares sold	5.48% sold Direct holding	▾
Dec 5, 2024	Humer Franz B Director	Sale	$19.92K 9,221 shares sold	2.91% sold Direct holding	▾
Jun 18, 2024	MESSEMER DEBORAH M. Director	Sale10b5-1 footnote	$42.49K 18,641 shares sold	10.05% sold Direct holding	▾
May 30, 2024	Humer Franz B Director	Sale	$26.18K 11,200 shares sold	4.20% sold Direct holding	▾
May 16, 2024	Belldegrun Arie Director	Purchase	$5.00M 1,724,137 shares bought	Unavailable Indirect holding	▾
Jan 30, 2024	Parker Geoffrey M. CHIEF FINANCIAL OFFICER	Purchase	$683.05 190 shares bought	0.02% added Direct holding	▾

Showing 6 / 6 record groups in 2024. The complete set is available through the API.

Allogene Therapeutics, Inc. · ALLO

Follow the people behind the trades.

Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.

Download CSV
Earlier filings
Advanced screening & filtering
API & AI access

Already have an account?

＋ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 6 of 6 purchase / sale groups and 29 of 29 other groups; the totals and the monthly series cover the whole window.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.

MCP  https://api.akkrudata.ai/mcp

akkru_insider_transactions
{"action":"list","ticker":"ALLO","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint: https://api.akkrudata.ai/mcp
API / MCP / CLI documentation: /documents
llms.txt: /llms.txt

Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

Non-cancelled, non-derivative purchase (P) and sale (S) rows dated inside the public window, as reported. Share totals are on today's split-adjusted basis. Includes open-market and private transactions. Data after the latest filing is not asserted complete and is not zero-filled. A grouped event shares filing, transaction date, security, code, direction, ownership bucket and source. Derivative groups also match underlying security, exercise price, exercise/expiration dates and footnote references. Reported rows are retained; P/S price lots can be grouped. Post-transaction balances are never summed.